when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Pulmonology · news · pharmadog

← back to Pulmonology

News · Pulmonology

513 stories

Aug 4, 26Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journeyfiercebiotech

Aug 4, 26Pathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamabbiospace

Aug 4, 26Merck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in SSc-ILDendpoints

Aug 4, 26Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trialsfiercebiotech

Aug 4, 26Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelcaraps

Aug 3, 26BioNTech taps Sobi executive Oelkers as its next CEObiopharma dive

Aug 3, 26New York’s assisted-dying law moves forwardstat

Aug 3, 26BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechbiospace

Aug 3, 26‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal everbiospace

Aug 3, 26BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challengerfiercebiotech

Aug 3, 26Heart transplant candidates fail if they get too weak. New program tries inpatient prehabstat

Aug 3, 26After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech

Aug 3, 26Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad ideafiercebiotech

Jul 30, 26Regeneron’s ‘aversion’ to M&A questioned as bumper Q2 builds war chestbiospace

Jul 30, 26Daiichi’s pipeline falls behind rivals as cash flow nears peak: analystsbiospace

Jul 30, 26Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemptionstat

Jul 30, 26New funding, new jobs: 4 biotechs hiring after series B raisesbiospace

Jul 30, 26Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continuesfiercebiotech

Jul 29, 26Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushbiopharma dive

Jul 29, 26Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combinationfiercebiotech

Jul 29, 267 companies hiring in New York nowbiospace

Jul 28, 26GSK prepares for patent cliff with $2.5B cost-cutting planbiopharma dive

Jul 28, 26GSK shares rise as $2.5B cost-cutting plan unveiledbiospace

Jul 28, 26GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyardfiercebiotech

Jul 28, 26After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenstat

Jul 28, 26STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDstat

Jul 28, 26GSK partner Hansoh reports another phase 3 win for priority ADCfiercebiotech

Jul 27, 26Gossamer regains rights to lung disease asset from Chiesi after Phase 3 failbiospace

Jul 27, 26AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failurebiospace

Jul 27, 26After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaborationfiercebiotech

← prevpage 10 of 18next →